Trial Information

Summary: A randomised, double-blind, placebo-controlled, multicenter prospective dose-finding Phase II/III study with atacicept given subcutaneously to subjects having recently experienced a flare of systemic lupus erythematosus (SLE)

The Lupus Center at Brigham and Women’s Hospital is conducting a study of atacicept for the treatment of lupus. The research study is called the APRIL study. It is hoped that atacicept will stop lupus flares. You must be in a flare to enter this study.

If you are interested in learning more about this study at Brigham and Women’s Hospital, please contact Victoria Gall, the study coordinator (617 732-5080, vgall@partners.org) or Dr. Elena Massarotti (617 732-6523 or emassarotti@partners.org)

Contact:

Victoria Gall
BWH - Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115
Telephone: 617 732-5080
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 17, 2008 at 2:55:08 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA